Regulatory issues are manufacturers' main concern:
This article was originally published in Clinica
Medical technology companies have said that regulatory issues, including the medical device directives and other developments in European regulations, are their most important concerns, a survey has found. The February 1999 telephone survey of visitors to the European trade exhibition, Medtec, discovered that 34% were most concerned about meeting and keeping up with regulatory changes, while 31% said sourcing reliable and quality suppliers was their biggest problem. 18% of respondents said new technology and product development was their main concern, with a further 11% citing developments in materials and plastics as the most important issue.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.